Your fact-checks will appear here
American pharmaceutical company
Donald Trump publicly disclosed he received an experimental monoclonal‑antibody infusion — Regeneron’s REGN‑COV2 cocktail — after his COVID‑19 diagnosis in early October 2020; contemporary reporting p...
President Donald Trump publicly acknowledged and his medical team disclosed that he received an experimental monoclonal‑antibody cocktail from Regeneron and a five‑day course of the antiviral remdesiv...
that were effective early in the pandemic have lost potency against successive , and by late 2022–2024 many authorized anti‑Spike mAbs show markedly reduced neutralizing activity against newer lineage...
There were clear controversies and intense public scrutiny over Dr. Sean Conley’s conduct and communications while treating President Trump in October 2020—principally about what he revealed to the pu...
Sean P. Conley served as Physician to the President from 2018 through 2021 and drew public scrutiny during President Trump’s COVID-19 illness in October 2020 for inconsistencies and inaccuracies in pu...
The supplied reporting does not include any contemporary news or statements documenting how President Trump or White House officials reacted to Dr. Sean Conley’s resignation; available items discuss C...
Dr. Sean Conley’s October 2020 briefings portrayed President Trump as improving and largely “doing very well,” while announcing specific treatments — Regeneron’s antibody cocktail, a five‑day course o...
Available search results do not mention a company or product named “RegeniJoint,” and they contain no FDA approval or clinical-trial records tied to that name (available sources do not mention RegeniJ...